The global drugs market is a complex and ever-evolving industry, encompassing a wide range of products, from prescription medications to illicit substances. In this article, we will explore the various aspects of the drugs market, including its size, growth trends, key players, and regulatory environment.
Furthermore, the main players face difficulties due to the lockdown, travel ban, and social distancing in the availability of generic drugs. China supplies about 70% of active pharmaceutical ingredients, and the coronavirus affected the generic drug supply. The Association of Accessible Medicines (AAM) discovered that travel and transportation costs increased by 224%.
Market Size and Growth
On a global scale, the World Health Organization (WHO) paints a somber picture, attributing almost 38 million annual deaths to chronic diseases. The rising drug patent expirations are notably driving the generic drug market growth. Increasing patent expirations are helping other drug companies, such as Abbott, to produce generic drugs with the same APIs as brand-name drugs. The expiration of patent drugs gives such companies the opportunity to design branded drugs and make them more affordable because when the patent expires, the company’s drug monopoly ceases to exist.
Category-wise Insights
According to a report by Grand View Research, the global pharmaceuticals market size was valued at USD 1.27 trillion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 5.2% from 2021 to 2028. This growth is driven by several factors, including an aging population, increasing prevalence of chronic diseases, and advances in medical technology.
- For established drug companies, current revenue streams from existing products also provide an important source of financing for their R&D projects.
- Additionally, the College of Pharmacy (Chicago, Rockford, US) has received multiple grants from the National Institutes of Health (NIH).
- The rising drug patent expirations are notably driving the market growth, although factors such as stringent regulations may impede the market growth.
- Small companies not in PhRMA devote a greater share of their research to developing and testing new drugs, many of which are ultimately sold to larger firms (see Box 1).
- Although females are not treated as equals to males, they typically hold more power than their culture allows and acquire some independence.
As per the same source, the global prevalence rate of self-medication ranged from 11.2% to 93.7%, depending on the target population and country. Thus, the high cost of Rx drugs leading to the use of OTC drugs is expected to drive market growth. The COVID-19 outbreak had a negative impact on most countries in North America, but the impact on the regional generic how can i buy fentanyl was mixed. As pharmaceuticals were considered essential services, the availability of and demand for generic drugs were not disrupted in the region. In 2021, generic drugs, like other pharmaceutical products, remained accessible to relevant stakeholders. These factors will contribute to the growth of the regional market during the forecast period.
Professional Development
On the other hand, the illicit drugs market is also thriving, with the global market for cocaine alone estimated to be worth over $100 billion annually. According to the United Nations Office on Drugs and Crime (UNODC), the global production of opium reached a record high of 10,500 metric tons in 2017, while the production of cocaine reached a record high of 1,976 metric tons in 2016.
Key Players
FDA Approves First Cellular Therapy To Treat Patients With Unresectable Or Metastatic Melanoma
The market for sophisticated topical products is likely to rise in the coming years, as topical drug administration is the first line of treatment for the majority of skin illnesses. Patent protection granted to branded drugs can pose a significant barrier to the entry of generic competitors. Pharmaceutical companies invest heavily in research and development to develop new drugs, and patents provide them with exclusive rights to manufacture and sell these drugs for a specified period. Generic manufacturers must wait for patents to expire or challenge them through legal means, which can delay market entry and increase litigation costs. To better understand changes in drug use outcomes and policies, policymakers need to know what is happening in the markets for these substances. The report also includes a discussion of what additional types of data would help quantify the scale of these markets in the future, including the new types of information produced by the legalization of marijuana at the state level.
The drugs market is dominated by a few large multinational corporations, such as Johnson & Johnson, Pfizer, and Merck & Co.. These companies have a significant presence in both the prescription medications and over-the-counter (OTC) markets.
The active pharmaceutical ingredient (API) of over the counter (OTC) drugs is usually regulated rather than the end product. Governments can freely create chemicals, or combinations of ingredients, into proprietary mixes by controlling APIs rather than specific medication formulations. Additionally, various organic and inorganic strategies adopted by the key market players are expected to support the growth of the market. In February 2022, Jamp Pharma Group launched Guanfacine XR, a generic version of the reference product INTUNIV XR from Takeda Canada Inc. that treats attention deficit hyperactivity disorder (ADHD). Moreover, in October 2021, The Yangtze River Pharmaceutical Group in China submitted the first marketing application for eslicarbazepine acetate, a class 3 generic medication used to treat epileptic patients. In addition, in July 2021, Generic Ferumoxytol, an injectable drug used to treat iron deficiency anemia (IDA), was launched in the United States by Sandoz, a global leader in generic and biosimilar medicines.
In the illicit dark web drug marketplace, the landscape is more fragmented, with various criminal organizations and cartels controlling different parts of the supply chain. Some of the most notorious drug trafficking organizations include the Sinaloa Cartel in Mexico and the MedellÃn Cartel in Colombia.
Can I get 2-dollar bills at my bank?
While the note is less common, $2 bills are still being printed (108.3 million entered circulation in 2022) and count as legal tender. You can even pick them up at a bank, though it'll likely only feature the design that took to the presses in 1976.
Regulatory Environment
The is heavily regulated, with various government agencies overseeing the production, distribution, and sale of medications. In the United States, the Food and Drug Administration (FDA) is responsible for ensuring the safety and efficacy of drugs, while the Drug Enforcement Administration (DEA) oversees the regulation of controlled substances.
In the illicit drugs market, the regulatory environment is much more lax, with criminal organizations and cartels operating outside the law. However, governments around the world are taking steps to combat drug trafficking, including increasing penalties for drug-related crimes and strengthening international cooperation.
FAQs
- What is the size of the global drugs market? The global drugs market is valued at over $1 trillion, with the pharmaceuticals market expected to grow at a CAGR of 5.2% from 2021 to 2028.
- Who are the key players in the drugs market? The drugs market is dominated by a few large multinational corporations, such as Johnson & Johnson, Pfizer, and Merck & Co. In the illicit drugs market, the landscape is more fragmented, with various criminal organizations and cartels controlling different parts of the supply chain.
- How is the drugs market regulated? The drugs market is heavily regulated, with various government agencies overseeing the production, distribution, and sale of medications. In the United States, the Food and Drug Administration (FDA) is responsible for ensuring the safety and efficacy of drugs, while the Drug Enforcement Administration (DEA) oversees the regulation of controlled substances. In the illicit drugs market, the regulatory environment is much more lax, with criminal organizations and cartels operating outside the law.
In conclusion, the drugs market is a complex and dynamic industry, with various factors influencing its size, growth, and regulatory environment. While the prescription medications and OTC markets are dominated by a few large multinational corporations, the illicit drugs market is controlled by various criminal organizations and cartels. Governments around the world are taking steps to combat drug trafficking, including increasing penalties for drug-related crimes and strengthening international cooperation. Despite these efforts, the drugs market remains a significant challenge for policymakers and regulators alike.
Who was the biggest Mexican drug lord?
Joaquín "El Chapo" Guzmán
Guzman is the most notorious drug lord of all time, according to the U.S. Drug Enforcement Administration (DEA). In the 1980s, he was a member of the Guadalajara Cartel and used to work for Miguel Ángel Félix Gallardo.
